Tricia Rodriguez, Truveta senior applied research scientist & lead study author, explains the study findings concerning why ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly ...

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

The study of more than two million veterans with diabetes details GLP-1 RA use relating to 175 outcomes; without ...

How and why the drugs have such wide-ranging health benefits is subject to further research, and the GLP-1 drugs were found ...

GLP-1 drugs like Ozempic have swept the world as effective therapies for far more than their original target of diabetes.

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

Snack foods and sweet treats have seen a decline in purchases, as people reach for more nutrient-dense options.

Insights from a study on GLP-1 receptor agonists reveal benefits for cardiometabolic health, with notable risks for ...

Though they found more benefits associated with the GLP-1 drugs than risks, study author Dr. Ziyad Al-Aly, who is chief of research and development at the VA St. Louis Health Care System, said ...